SARS-CoV-2 has rapidly spread across the globe and infected hundreds of millions of
people worldwide. As our experience with this virus continues to grow, our understanding of …

Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …

Summary Coronavirus disease 2019 (COVID-19) represents a systemic disease that may
cause severe metabolic complications in multiple tissues including liver, kidney, and …

Coronaviruses are constantly circulating in humans, causing common colds and mild
respiratory infections. In contrast, infection with the novel severe acute respiratory syndrome …

Obesity, diabetes mellitus (mostly type 2), and COVID-19 show mutual interactions because
they are not only risk factors for both acute and chronic COVID-19 manifestations, but also …

Convergence of the two pandemics: metabolic syndrome and COVID-19 over last two years
has posed unprecedented challenges to individuals as well as healthcare systems …

In December 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2
(SARS‐CoV‐2) was identified in Wuhan, China and has since resulted in a global pandemic …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) dysregulates antiviral
signaling, immune response, and cell metabolism in human body. Viral genome and …

Alcohol-associated liver disease (ALD) represents one of the deadliest yet preventable
consequences of excessive alcohol use. It represents 5.1% of the global burden of disease …

The outbreak and worldwide spread of coronavirus disease 2019 (COVID-19), which is
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a …